Amgen's first quarter earnings beat analyst estimates

You are here: Home > Biotech > Current Article

Amgen’s first quarter earnings beat analyst estimates

By Staff Report / Thursday, April 30th, 2020 / Comments Off on Amgen’s first quarter earnings beat analyst estimates

Thousand Oaks-based biotech giant Amgen's revenues rose 11 percent in the first quarter to $6.2 billion but earnings per share dipped 3 percent to $3.07 apiece.  Sales volumes increased, offset by lower overall prices, Amgen said in filings with regulators April 30. Net income fell 8 percent compared to the previous first quarter to $1.83…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.